Skip Navigation


Human Molecular Genetics Advance Access originally published online on August 7, 2006
Human Molecular Genetics 2006 15(18):2690-2700; doi:10.1093/hmg/ddl201
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
15/18/2690    most recent
ddl201v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Gawlik, K. I.
Right arrow Articles by Durbeej, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gawlik, K. I.
Right arrow Articles by Durbeej, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Laminin {alpha}1 chain improves laminin {alpha}2 chain deficient peripheral neuropathy

Kinga I. Gawlik1, Jia-Yi Li2, Åsa Petersén2 and Madeleine Durbeej1,*

1 Muscle Biology Unit, Division for Cell and Matrix Biology and 2 Neuronal Survival Unit, Department of Experimental Medical Science, University of Lund, Lund, Sweden

* To whom correspondence should be addressed at: Division for Cell and Matrix Biology, Department of Experimental Medical Science, University of Lund, BMC B12, 221 84 Lund, Sweden. Tel: +46 462220812; Fax: +46 462220855; Email: madeleine.durbeej-hjalt{at}med.lu.se

Received June 15, 2006; Accepted July 27, 2006

Absence of laminin {alpha}2 chain leads to a severe form of congenital muscular dystrophy (MDC1A) associated with peripheral neuropathy. Hence, future therapies should be aimed at alleviating both muscle and neurological dysfunctions. Pre-clinical studies in animal models have mainly focused on ameliorating the muscle phenotype. Here we show that transgenic expression of laminin {alpha}1 chain in muscles and the peripheral nervous system of laminin {alpha}2 chain deficient mice reduced muscular dystrophy and largely corrected the peripheral nerve defects. The presence of laminin {alpha}1 chain in the peripheral nervous system resulted in near-normal myelination, restored Schwann cell basement membranes and improved rotarod performance. In summary, we postulate that laminin {alpha}1 chain is an excellent substitute for laminin {alpha}2 chain in multiple tissues and suggest that treatment with laminin {alpha}1 chain may be beneficial for MDC1A in humans.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Cell Sci.Home page
B. L. Patton, B. Wang, Y. S. Tarumi, K. L. Seburn, and R. W. Burgess
A single point mutation in the LN domain of LAMA2 causes muscular dystrophy and peripheral amyelination
J. Cell Sci., May 15, 2008; 121(10): 1593 - 1604.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. Xu, K. Chandrasekharan, J. H. Yoon, M. Camboni, and P. T. Martin
Overexpression of the Cytotoxic T Cell (CT) Carbohydrate Inhibits Muscular Dystrophy in the dyW Mouse Model of Congenital Muscular Dystrophy 1A
Am. J. Pathol., July 1, 2007; 171(1): 181 - 199.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.